This funding opportunity supports research units conducting studies on early detection of pancreatic ductal adenocarcinoma (PDAC) and its precursor lesions. Funded activities include biomarker discovery and validation using molecular and imaging techniques, machine learning approaches, and collection of longitudinal biospecimens for a biorepository. Collaborative data and biospecimen sharing within the consortium is required to accelerate early intervention strategies for high-risk patients.
Eligible applicants include U.S. state, county, city, and special district governments; public and private higher education institutions; Native American tribal governments and organizations; nonprofits; for-profit organizations excluding small businesses; and small businesses. Foreign organizations
